StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)

Equities researchers at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued on Sunday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Shares of AVGR opened at $0.47 on Friday. Avinger has a twelve month low of $0.36 and a twelve month high of $4.37. The firm’s fifty day simple moving average is $0.64 and its 200-day simple moving average is $0.82. The firm has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.